Business · 1 sources covering this

Sun Pharma Hits 52-Week High After South Africa Approves GLP-1 Drug Semaglutide

Sun Pharmaceutical shares hit a 52-week high after receiving approval to market generic semaglutide injection in South Africa for type 2 diabetes treatment.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·3h ago
Sun Pharma Hits 52-Week High After South Africa Approves GLP-1 Drug Semaglutide
Sun Pharmaceutical shares hit a 52-week high after receiving approval to market generic semaglutide injection in South Africa for type 2 diabetes treatment.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/6e701b232fd2d6977eaeb8690b55b2be10aee7ef"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Sun Pharma Hits 52-Week High After South Africa Approves GLP-1 Drug Semaglutide"></iframe>

Sun Pharma Hits 52-Week High After South Africa Approves GLP-1 Drug Semaglutide

How 1 sources are covering this

Sun Pharma Hits 52-Week High After South Africa Approves GLP-1 Drug Semaglutide

More from Business

‘Are you from the future?’: 5-year-old prediction about FIFA World Cup 2026 final leaves social media stunned

Mob attacks Assam Rifles camp in Manipur, torches vehicles after search operation

‘Rent is the price for freedom’: Vlogger shares top 5 parenting moments of wisdom of her family

FIR filed over alleged fake social media campaign targeting Nitin Gadkari on E20 fuel

Reader

Trust & legal

Across the network